Call for Abstracts

You are invited to participate in the 12^th Conference on Osteoporosis by submitting an abstract that describes research or innovations in the areas of osteoporosis and/or metabolic bone disease.

Authors submitting abstracts should intend for them to be presented at the Conference. Authors may submit abstracts of completed work, work in progress, or work presented at a local or regional level.  An abstract may be submitted that has been previously published as an abstract, presented orally or as a poster, or presented at a regional meeting. The primary author must obtain consent from all authors and appropriate institutional clearances prior to submission, and complete necessary disclosure and attestation forms.  

POSTER FEES AND EXPENSES

Presenter must pay the appropriate registration fee for the SMA Conference, and is responsible for all travel and subsidence expenses.

REVIEW/ACCEPTANCE PROCEDURE

The Deadline for receipt of Abstracts is December 15, 2008.  At that time, the Activity Chair will review the submission, and notification of acceptance will be mailed mid-January.   Abstracts will be reviewed based on the following criteria:

1. Topic: Is the topic significant/important/of relevance to osteoporosis/metabolic bone disease?  Is this an innovative, cutting-edge topic?
2. Background/Rationale: Is the rationale for the topic logical and supported by clinical information?
3. Interventions: Are the interventions and/or practices described appropriate for the topic?  Are the data/observations adequately documented?
4. Interpretation: Are the clinical practice outcomes applicable? Presentation: Is the abstract well written? Are the ideas clearly communicated?
5. Conclusions:  Are the conclusions justified by the data presented?

GUIDELINES FOR SUBMISSION

Preferred method of submission is in Microsoft Word format, submitted via email. 

INDICATE on the first line of the document the appropriate REVIEW CATEGORY for your submission, selecting one of the following:

• Central DXA
• Peripheral DXA/SXA
• QCT/Peripheral QCT
• Ultrasonometry
• Radiographic Absorptiometry
• MR Densitometry
• Assessment of Fracture Risk
• Monitoring Therapy
• Clinical Study Recruitment
• Patient Education
• Prevention and Treatment of Osteoporosis
• Epidemiology
• Assessment of Bone Quality
• Case Report
• Other (indicate:  _________)

TYPE the TITLE in CAPITAL LETTERS on the first line (flush left). On the next line (do not skip a line), type author(s) name(s), flush left using upper and lower case, with initials separated by periods preceding surname. Use a comma between other information items. Presenting author should be listed first and the name underlined. Institution’s name, city and state should follow.  Be sure to check with abstract co-authors for correct attribution.

ORGANIZE the body of the abstract in four paragraphs, single-spaced, to include:  Purpose, Methods, Results, and Conclusions.  The abstract should be no more than 350 words - excluding the title and authors’ name(s).  Preferred font size is 12 point Times New Roman.

PROVIDE name, degree, institution, mailing address, phone and fax numbers, and email address for PRESENTING AUTHOR only.  All correspondence regarding the submission will be sent only to this person.

QUESTIONS/SUBMISSION INFORMATION

Questions regarding submissions can be directed to:  Mandy Stone, Southern Medical Association, phone, toll-free:  800.423.4992, ext. 132; direct:  205.421.4132; or email:  mstone@sma.org. 

Abstracts (in Microsoft Word Format) should be emailed as an attachment to:  mstone@sma.org.  Submission must be emailed ON OR BEFORE December 15, 2008.